Neuland Laboratories- A dedicated 100% API provider.
01 1Neuland Laboratories Limited
02 1Aurobindo Pharma Limited
03 1Cadila Pharmaceuticals Limited
04 1Cipla Ltd.
05 1Glenmark Life Sciences Limited
06 1Honour Lab Limited
07 1Jubilant Pharmova Limited
08 1MSN Laboratories Private Limited
09 2MYLAN LABORATORIES LIMITED
10 1Viyash Life Sciences Private Limited
11 1Zydus Lifesciences Limited
01 2BOSENTAN
02 1BOSENTAN MONOHYDRATE
03 3Bosentan
04 4Bosentan Monohydrate
05 1bosentan
06 1bosentan monohydrate
01 10India
02 2U.S.A
Neuland Laboratories- A dedicated 100% API provider.
NDC Package Code : 58032-2016
Start Marketing Date : 2017-12-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-796
Start Marketing Date : 2023-12-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65691-0084
Start Marketing Date : 2013-03-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7703
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-870
Start Marketing Date : 2011-08-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1184
Start Marketing Date : 2014-09-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0041
Start Marketing Date : 2010-03-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-753
Start Marketing Date : 2015-01-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-770
Start Marketing Date : 2015-02-24
End Marketing Date : 2026-12-01
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65841-176
Start Marketing Date : 2018-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Bosentan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bosentan, including repackagers and relabelers. The FDA regulates Bosentan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bosentan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bosentan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bosentan supplier is an individual or a company that provides Bosentan active pharmaceutical ingredient (API) or Bosentan finished formulations upon request. The Bosentan suppliers may include Bosentan API manufacturers, exporters, distributors and traders.
click here to find a list of Bosentan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bosentan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bosentan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bosentan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bosentan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bosentan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bosentan suppliers with NDC on PharmaCompass.
We have 11 companies offering Bosentan
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
